New cast for a new era: preclinical cancer drug development revisited

GS Herter-Sprie, AL Kung… - The Journal of clinical …, 2013 - Am Soc Clin Investig
Molecularly targeted agents promise to revolutionize therapeutics by reducing morbidity and
mortality in patients with cancer. However, despite an urgent need for more effective …

Imaging mouse models of cancer

SK Lyons - The Cancer Journal, 2015 - journals.lww.com
Mouse models of cancer have proven to be an indispensable resource in furthering both our
basic knowledge of cancer biology and the translation of new cancer treatments and …

A clinically relevant computed tomography (CT) radiomics strategy for intracranial rodent brain tumour monitoring

K Connor, E Conroy, K White, LP Shiels, S Keek… - Scientific Reports, 2024 - nature.com
Here, we establish a CT-radiomics based method for application in invasive, orthotopic
rodent brain tumour models. Twenty four NOD/SCID mice were implanted with U87R-Luc2 …

Highly invasive fluorescent/bioluminescent patient-derived orthotopic model of glioblastoma in mice

D Yuzhakova, E Kiseleva, M Shirmanova… - Frontiers in …, 2022 - frontiersin.org
Development of the novel diagnostic and therapeutic approaches in neuro-oncology
requires tumor models that closely reproduce the biological features of patients' tumors …

Sonoporation for augmenting chemotherapy of pancreatic ductal adenocarcinoma

J Castle, S Kotopoulis, F Forsberg - Drug Delivery Systems, 2020 - Springer
Pancreatic cancer is the third most common cancer diagnosed in the United States, with
more than 53,000 new cases in 2017. It is the fourth leading cause of cancer-related death …

Interrogation of gossypol therapy in glioblastoma implementing cell line and patient-derived tumour models

MA Jarzabek, V Amberger-Murphy, JJ Callanan… - British journal of …, 2014 - nature.com
Background: Glioblastoma (GBM), being a highly vascularised and locally invasive tumour,
is an attractive target for anti-angiogenic and anti-invasive therapies. The GBM/endothelial …

Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant

Z Zakaria, A Tivnan, L Flanagan, DW Murray… - British journal of …, 2016 - nature.com
Background: Resistance to temozolomide (TMZ) greatly limits chemotherapeutic
effectiveness in glioblastoma (GBM). Here we analysed the ability of the Inhibitor-of …

A New Systemic Disease Mouse Model for Glioblastoma Capable of Single-Tumour-Cell Detection

TMB Ware, RB Luwor, HJ Zhu - Cells, 2024 - mdpi.com
Background: Glioblastoma is characterised by extensive infiltration into the brain
parenchyma, leading to inevitable tumor recurrence and therapeutic failure. Future …

Pre-clinical imaging for establishment and comparison of orthotopic non-small cell lung carcinoma: in search for models reflecting clinical scenarios

R Aktar, A Dietrich, F Tillner, S Kotb… - The British Journal of …, 2019 - academic.oup.com
Objective: Clinically relevant animal models of non-small cell lung carcinoma (NSCLC) are
required for the validation of novel treatments. We compared two different orthotopic …

First in-mouse development and application of a surgically relevant xenograft model of ovarian carcinoma

Ø Helland, M Popa, OK Vintermyr, A Molven… - PloS one, 2014 - journals.plos.org
Purpose Preclinical models of epithelial ovarian cancer have not been exploited to evaluate
the clinical standard combination therapy of surgical debulking with follow-up …